Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 5, 2009 - Issue 6
Submit an article Journal homepage
886
Views
33
CrossRef citations to date
0
Altmetric
Drug Evaluations

Thiazolides: a new class of antiviral drugs

Jean-François Rossignol The Romark Institute for Medical Research, 3000 Bayport Drive, Suite 200, Tampa, Florida 33607, USA +1 813 282 8544; +1 813 282 4910; [email protected]
, MD PhD
Pages 667-674 | Published online: 15 May 2009

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

John Halliday, Paul Klenerman & Eleanor Barnes. (2011) Vaccination for hepatitis C virus: closing in on an evasive target. Expert Review of Vaccines 10:5, pages 659-672.
Read now

Articles from other publishers (32)

Kenneth M. Pfarr, Anna K. Krome, Issraa Al-Obaidi, Hannah Batchelor, Michel Vaillant, Achim Hoerauf, Nicholas O. Opoku & Annette C. Kuesel. (2023) The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use. Parasites & Vectors 16:1.
Crossref
Drugan K. Brady, Aashi R. Gurijala, Liyu Huang, Ali A. Hussain, Audrey L. Lingan, Olivia G. Pembridge, Brina A. Ratangee, Tristan T. Sealy, Kyle T. Vallone & Thomas P. Clements. (2022) A guide to COVID ‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV ‐2 infection . The FEBS Journal.
Crossref
Lauren E. Walker, Richard FitzGerald, Geoffrey Saunders, Rebecca Lyon, Michael Fisher, Karen Martin, Izabela Eberhart, Christie Woods, Sean Ewings, Colin Hale, Rajith K. R. Rajoli, Laura Else, Sujan Dilly‐Penchala, Alieu Amara, David G. Lalloo, Michael Jacobs, Henry Pertinez, Parys Hatchard, Robert Waugh, Megan Lawrence, Lucy Johnson, Keira Fines, Helen Reynolds, Timothy Rowland, Rebecca Crook, Emmanuel Okenyi, Kelly Byrne, Pavel Mozgunov, Thomas Jaki, Saye Khoo, Andrew Owen, Gareth Griffiths & Thomas E. Fletcher. (2021) An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2. Clinical Pharmacology & Therapeutics 111:3, pages 585-594.
Crossref
Alexandra Ivoilova, Ludmila V. Mikhalchenko, Anton Tsmokalyuk, Marina Leonova, Andrey Lalov, Polina Mozharovskaia, Alisa N. Kozitsina, Alla V. Ivanova & Vladimir L. Rusinov. (2021) Redox Conversions of 5-Methyl-6-nitro-7-oxo-4,7-dihydro-1,2,4triazolo[1,5-a]pyrimidinide L-Arginine Monohydrate as a Promising Antiviral Drug. Molecules 26:16, pages 5087.
Crossref
Andrew V. StachulskiJoshua TaujanskasSophie L. PateRajith K. R. RajoliGhaith AljayyoussiShaun H. PenningtonStephen A. WardWeiqian David Hong, Giancarlo A. BiaginiAndrew OwenGemma L. Nixon, Suet C. LeungPaul M. O’Neill. (2020) Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?. ACS Infectious Diseases 7:6, pages 1317-1331.
Crossref
S Rakedzon, A Neuberger, A J Domb, N Petersiel & E Schwartz. (2021) From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?. Journal of Travel Medicine 28:2.
Crossref
Amit S. Lokhande & Padma V. Devarajan. (2021) A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. European Journal of Pharmacology 891, pages 173748.
Crossref
Ferrin Antony, Yoya Vashi, Sudhir Morla, Vandna, Hari Mohan & Sachin Kumar. (2020) Therapeutic potential of Nitazoxanide against Newcastle disease virus: A possible modulation of host cytokines. Cytokine 131, pages 155115.
Crossref
Sean AinsworthSean Ainsworth. 2020. Neonatal Formulary. Neonatal Formulary 537 566 .
Mohammad Amin Behzadi & Victor H. Leyva-Grado. (2019) Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections. Frontiers in Microbiology 10.
Crossref
Armando Arias. 2019. Norovirus. Norovirus 101 155 .
Latavia Singh, Sunaina Indermun, Mershen Govender, Pradeep Kumar, Lisa du Toit, Yahya Choonara & Viness Pillay. (2018) Drug Delivery Strategies for Antivirals against Hepatitis B Virus. Viruses 10:5, pages 267.
Crossref
Andrew V Stachulski, M Gabriella Santoro, Sara Piacentini, Giuseppe Belardo, Simone La Frazia, Chandrakala Pidathala, Eleanor C Row, Neil G Berry, Mazhar Iqbal, Sarah A Allman, J Edward Semple, Brian M Eklov, Paul M O'Neill & Jean-Francois Rossignol. (2018) Second-generation nitazoxanide derivatives: thiazolides are effective inhibitors of the influenza A virus. Future Medicinal Chemistry 10:8, pages 851-862.
Crossref
Ludmila Perelygina, Timo Hautala, Mikko Seppänen, Adebola Adebayo, Kathleen E. Sullivan & Joseph Icenogle. (2017) Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency. Antiviral Research 147, pages 58-66.
Crossref
Veaceslav Boldescu, Mira A. M. Behnam, Nikos Vasilakis & Christian D. Klein. (2017) Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Nature Reviews Drug Discovery 16:8, pages 565-586.
Crossref
Valerie J. Wiebe. 2015. Drug Therapy for Infectious Diseases of the Dog and Cat. Drug Therapy for Infectious Diseases of the Dog and Cat 247 296 .
Zixue Shi, Jianchao Wei, Xufang Deng, Shuqing Li, Yafeng Qiu, Donghua Shao, Beibei Li, Keyu Zhang, Feiqun Xue, Xiaodu Wang & Zhiyong Ma. (2014) Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model. Virology Journal 11:1.
Crossref
Gordana Panic, Urs Duthaler, Benjamin Speich & Jennifer Keiser. (2014) Repurposing drugs for the treatment and control of helminth infections. International Journal for Parasitology: Drugs and Drug Resistance 4:3, pages 185-200.
Crossref
. 2014. Neonatal Formulary 7. Neonatal Formulary 7 57 553 .
Kristiana Nikolova, Christian Gluud, Berit Grevstad & Janus C Jakobsen. (2014) Nitazoxanide for chronic hepatitis C. Cochrane Database of Systematic Reviews.
Crossref
Andreas Jurgeit, Robert McDowell, Stefan Moese, Eric Meldrum, Reto Schwendener & Urs F. Greber. (2012) Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects. PLoS Pathogens 8:10, pages e1002976.
Crossref
Andrew V. StachulskiChandrakala PidathalaEleanor C. RowRaman SharmaNeil G. BerryAlexandre S. LawrensonShelley L. MooresMazhar IqbalJoanne BentleySarah A. AllmanGeoffrey EdwardsAlison HelmJennifer HellierBrent E. Korba, J. Edward Semple & Jean-Francois Rossignol. (2011) Thiazolides as Novel Antiviral Agents. 2. Inhibition of Hepatitis C Virus Replication. Journal of Medicinal Chemistry 54:24, pages 8670-8680.
Crossref
Danish M. Siddiq, Hoonmo L. Koo, Javier A. Adachi & George M. Viola. (2011) Norovirus gastroenteritis successfully treated with nitazoxanide. Journal of Infection 63:5, pages 394-397.
Crossref
PAUL KELLY. (2011) Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia?. Parasitology 138:12, pages 1488-1491.
Crossref
Changsuek Yon, Prasanth Viswanathan, Jean-François Rossignol & Brent Korba. (2011) Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells. Antiviral Research 91:3, pages 233-240.
Crossref
Andrew V. StachulskiChandrakala PidathalaEleanor C. RowRaman SharmaNeil G. BerryMazhar IqbalJoanne BentleySarah A. AllmanGeoffrey EdwardsAlison HelmJennifer HellierBrent E. Korba, J. Edward Semple & Jean-Francois Rossignol. (2011) Thiazolides as Novel Antiviral Agents. 1. Inhibition of Hepatitis B Virus Replication. Journal of Medicinal Chemistry 54:12, pages 4119-4132.
Crossref
Kristiana Nikolova, Shahira Ahmed Afifi, Naglaa Zayed, Tahany Awad, Shereen Hunter, Ayman Amer, Christian Gluud & Mahasen Mabrouk. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Toshiaki Murai, Fumihiko Hori & Toshifumi Maruyama. (2011) Intramolecular Cyclization of in Situ Generated Adducts Formed between Thioamide Dianions and Thioformamides Leading to Generation of 5-Amino-2-thiazolines and 5-Aminothiazoles, and Their Fluorescence Properties. Organic Letters 13:7, pages 1718-1721.
Crossref
Lynn L. Silver. (2011) Challenges of Antibacterial Discovery. Clinical Microbiology Reviews 24:1, pages 71-109.
Crossref
Nishith Singh & S Narayan. (2011) Nitazoxanide : A Broad Spectrum Antimicrobial. Medical Journal Armed Forces India 67:1, pages 67-68.
Crossref
R. F. Schinazi, L. Bassit & C. Gavegnano. (2010) HCV drug discovery aimed at viral eradication. Journal of Viral Hepatitis 17:2, pages 77-90.
Crossref
Laura V. Ashton, Robert L. Callan, Sangeeta Rao & Gabriele A. Landolt. (2010) In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide . Veterinary Medicine International 2010, pages 1-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.